| Drug Name |
Tiagabine |
| Drug ID |
BADD_D02210 |
| Description |
Tiagabine is an anti-convulsive medication. It is also used in the treatment for panic disorder as are a few other anticonvulsants. Though the exact mechanism by which tiagabine exerts its effect on the human body is unknown, it does appear to operate as a selective GABA reuptake inhibitor. |
| Indications and Usage |
For the treatment of partial seizures |
| Marketing Status |
approved; investigational |
| ATC Code |
N03AG06 |
| DrugBank ID |
DB00906
|
| KEGG ID |
D08588
|
| MeSH ID |
D000078308
|
| PubChem ID |
60648
|
| TTD Drug ID |
D0ED7U
|
| NDC Product Code |
69238-1104; 69238-1106; 69238-1105; 69238-1107 |
| UNII |
Z80I64HMNP
|
| Synonyms |
Tiagabine | N-(4,4-di(3-Methylthien-2-yl)but-3-enyl)nipecotic acid | Gabitril | NO 329 | NO-329 | Tiagabine Hydrochloride | (R)-(4,4-bis(3-Methyl-2-thienyl)-3-butenyl)-3-piperidinecarboxylic acid, Hydrochloride | Tiagabine, (S)-isomer | NO 328 | NO-328 |
